Stock Market News

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

May 20, 2025 - 02:54
 0
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
Read More

Tags:

Previous Article

Kornit Digital: Decent Prospects Reflected In Premium Valuation - Hold

Next Article

Ford's CEO has a strong take on tariffs

Related Posts

Barclays still expects U.S. activity growth to slow

Barclays still expects U.S. activity growth to slow

May 19, 2025  0

Fortress sets up Abu Dhabi office, appoints regional head in push for Gulf growth

Fortress sets up Abu Dhabi office, appoints regional he...

May 14, 2025  0

Fitch awards first-time 'BB-' rating to CoreWeave, $1.5 billion senior notes included

Fitch awards first-time 'BB-' rating to CoreWeave, $1.5...

May 19, 2025  0